Lariat RNA structures resist serum nucleases and maintain 70% potency after seven days, solving rapid degradation in traditional siRNA therapies.
Internal spacers in an 18-mer RNA interference agent improve nuclease resistance and activity duration compared to standard siRNA formats.
Cholesterol-conjugated double-stranded RNA agents silence SGLT2 transcripts while resisting nuclease degradation in vivo.
LNA gapmers hybridize with DUX4 mRNA to suppress expression, addressing the lack of curative options for Facioscapulohumeral Muscular Dystrophy.
Lipophilic conjugated oligonucleotides inhibit specific microRNAs while resisting nucleolytic degradation during systemic circulation.
GalNAc-conjugated RNAi compositions silence C3 transcripts, avoiding invasive procedures and side effects like cataracts.
DNase I digestion removes weak binders during single-cycle selection, preserving sequence diversity and reducing process time compared to multi-round SELEX.
Modified oligonucleotides target nuclear lncRNAs to displace PRC2, resolving inefficiency in regulating gene expression for neurodegeneration therapies.
Circular ACE-tRNAs revert premature termination codons without ototoxicity or missense mutations.
Sb-TIP2-3 promoter sequences drive tissue-specific expression in plant roots, resolving the contradiction between continuous activity and spatial control.
RNA fragment with stem-loop structure induces defense gene expression to prevent bacterial resistance in plants.
Experimental screening of candidate sequences resolves the contradiction between rapid computational design and reliable inhibitory effectiveness.
siRNA silences HNF4α-P2 isoforms to treat liver failure, addressing ineffective conventional therapies that fail to improve hepatocyte function.
TREMs pair with mutant codons to increase isoacceptor tRNA abundance, restoring protein translation efficiency despite genetic variations.
Circular Tau-TfR bispecific aptamers cross the blood-brain barrier via transferrin receptor-mediated transcytosis, reducing Tau protein levels in brain tissue.
Segmented siRNA strands self-assemble into double-stranded structures with 3' overhangs to enhance stability and inhibit target mRNA levels.
Recombinant nucleic acid molecules form hairpin structures with specific mismatches to enhance RISC incorporation and gene knockdown.